KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $35.67 $42.36 Friday, 26th Apr 2024 CLDX stock ended at $36.30. This is 0.110% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 3.00% from a day low at $35.67 to a day high of $36.74.
90 days $34.65 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
Apr 12, 2016 $67.20 $69.00 $64.80 $68.40 253 987
Apr 11, 2016 $69.90 $71.55 $66.00 $67.35 207 491
Apr 08, 2016 $71.85 $72.75 $66.90 $70.05 200 829
Apr 07, 2016 $73.05 $74.40 $67.50 $70.65 337 789
Apr 06, 2016 $65.85 $73.35 $65.85 $73.35 311 602
Apr 05, 2016 $64.95 $69.75 $63.75 $65.70 252 919
Apr 04, 2016 $59.55 $67.80 $59.25 $65.55 359 175
Apr 01, 2016 $55.65 $59.40 $54.45 $59.25 178 390
Mar 31, 2016 $53.55 $58.05 $52.65 $56.70 194 576
Mar 30, 2016 $55.80 $59.55 $54.60 $56.10 130 331
Mar 29, 2016 $51.90 $55.95 $49.50 $55.65 152 333
Mar 28, 2016 $53.40 $54.30 $51.15 $52.05 90 653
Mar 24, 2016 $53.10 $54.60 $50.40 $52.95 158 727
Mar 23, 2016 $58.50 $60.00 $53.40 $53.55 231 200
Mar 22, 2016 $54.15 $59.85 $53.70 $58.35 326 353
Mar 21, 2016 $48.15 $54.45 $47.85 $54.15 382 600
Mar 18, 2016 $46.95 $48.60 $44.70 $48.45 670 573
Mar 17, 2016 $47.40 $48.45 $44.40 $47.55 222 013
Mar 16, 2016 $48.90 $49.95 $46.80 $48.15 249 520
Mar 15, 2016 $51.75 $52.20 $49.05 $49.20 247 107
Mar 14, 2016 $51.75 $54.75 $51.60 $52.20 312 440
Mar 11, 2016 $55.05 $55.05 $51.30 $52.20 332 707
Mar 10, 2016 $54.00 $56.10 $53.55 $54.15 227 027
Mar 09, 2016 $55.50 $56.85 $51.75 $54.30 300 853
Mar 08, 2016 $58.05 $61.20 $53.55 $55.20 510 993
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT